Our findings show that docetaxel remodels tumor microenvironment by promoting intratumoral infiltration of T cells and upregulating the abundance of PD1 and PD-L1, and show enhanced antitumor activity when combined with anti-PD1 blockade. Here, CD274 is linked to neoplasm.